Article Impact Level: HIGH Data Quality: STRONG Summary of CIRCRESAHA https://doi.org/10.1161/CIRCRESAHA.125.327858 Dr. Luisa C. Parnell et al.
Points
- University of Manchester researchers analyzed isolated omental microvessels from pregnant women establishing that preeclampsia causes a fundamental impairment in intrinsic maternal arterial relaxation mechanisms.
- Pressurized vessel testing revealed a seventy five percent reduction in calcium spark frequency and spontaneous transient outward currents under normal physiological vascular pressures.
- Cellular profiling identified sarcoplasmic reticulum depletion driven by increased unphosphorylated phospholamban inhibition of SERCA2 calcium pumps as the primary cause of impaired signaling.
- Ex vivo therapeutic testing demonstrated that human beta defensin two induced BKCa channel mediated vasodilation independently of defective calcium sparks to restore vessel relaxation.
- Authors concluded that targeting novel vasodilatory pathways bypassing microvascular signaling defects provides a promising pharmacological strategy to prolong pregnancy and control preeclamptic hypertension.
Summary
This study evaluated the physiological mechanisms underlying maternal microvascular dysfunction and elevated peripheral resistance in preeclampsia. Published in Circulation Research by researchers from the University of Manchester and Manchester University NHS Foundation Trust, the investigation addressed the pathophysiology of preeclampsia, which affects 2% to 8% of pregnancies globally. Given that current clinical management remains restricted to symptomatic blood pressure control and iatrogenic preterm delivery, the research sought to characterize intrinsic calcium signaling defects in resistance-sized maternal arteries and identify novel therapeutic targets to restore vascular relaxation.
Ex vivo pressurization experiments on small omental arteries isolated from pregnant women with and without preeclampsia revealed a profound impairment in myogenic relaxation pathways. In preeclamptic microvessels, localized sarcoplasmic reticulum calcium release events, known as calcium sparks, and associated spontaneous transient outward currents were severely blunted, demonstrating a frequency reduction of up to 75% under normal physiological pressures. Mechanistic analysis indicated that this calcium spark deficiency stems from increased inhibition of the sarcoplasmic reticulum calcium ATPase 2 (SERCA2) pump by unphosphorylated phospholamban (PLN), leading to depleted sarcoplasmic reticulum calcium stores and impaired store refilling. Crucially, administration of human beta-defensin 2 (HBD2) induced BKCa channel-mediated vasodilation independently of calcium sparks.
The authors conclude that impaired SERCA2-mediated calcium reuptake and a 75% reduction in microvascular calcium sparks represent a fundamental cellular defect driving systemic vasoconstriction in preeclampsia. Pharmacological activation of alternative vasodilatory pathways, such as HBD2-mediated BKCa activation that bypasses defective calcium spark machinery, offers a novel therapeutic strategy to control maternal hypertension, prolong gestation, and reduce preterm delivery requirements.
Link to the article: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.125.327858
References
Parnell, L. C., Tierney, A. L., Cottrell, E. C., Pritchard, H. A. T., Smith, M. N., Krakowiak, K., Unwin, R. D., Gurney, A. M., Myers, J. E., Greenstein, A., & Worton, S. A. (2026). Maternal microvascular calcium sparks are reduced in preeclampsia. Circulation Research, CIRCRESAHA.125.327858. https://doi.org/10.1161/CIRCRESAHA.125.327858
